Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Cuartero Rodriguez E"'
Autor:
Serrano-Castro PJ; Neurology Service, Regional University Hospital of Malaga, Malaga, Spain. pedro.serrano.c@uma.es.; Neuroimmunology and Neuroinflamation Group, Institute of Biomedical Research of Malaga (IBIMA), Malaga, Spain. pedro.serrano.c@uma.es.; Andalusian Network for Clinical and Translational Research in Neurology (NEURO-RECA), Malaga, Spain. pedro.serrano.c@uma.es.; Neurology Department, Instituto IBIMA, Hospital Regional Universitario de Málaga (España), Avda Carlos-Haya S/N, 4a planta, Malaga, Spain. pedro.serrano.c@uma.es., Garzón-Maldonado FJ; Neurology Service, Virgen de la Victoria University Hospital, Malaga, Spain.; Andalusian Network for Clinical and Translational Research in Neurology (NEURO-RECA), Malaga, Spain., Casado-Naranjo I; Neurology Service, University Hospital of Cáceres, Cáceres, Spain.; Biomedical Network Research Center for Neurodegenerative Diseases (CIBERNED), Madrid, Spain.; University Institute of Biosanitary Research of Extremadura (INUBE), Cáceres, Spain., Ollero-Ortiz A; Neurology Service, Valme University Hospital, Seville, Spain.; Andalusian Network for Clinical and Translational Research in Neurology (NEURO-RECA), Malaga, Spain., Mínguez-Castellanos A; Neurology Service, Virgen de las Nieves University Hospital, Granada, Spain.; Andalusian Network for Clinical and Translational Research in Neurology (NEURO-RECA), Malaga, Spain.; Institute of Biosanitary Research of Granada (Ibs. GRANADA), Granada, Spain., Iglesias-Espinosa M; Neurology Service, Torrecárdenas University Hospital, Almería, Spain.; Andalusian Network for Clinical and Translational Research in Neurology (NEURO-RECA), Malaga, Spain., Baena-Palomino P; Neurology Service, Juan Ramón Jiménez University Hospital, Huelva, Spain.; Andalusian Network for Clinical and Translational Research in Neurology (NEURO-RECA), Malaga, Spain., Sánchez-Sanchez V; Neurology Service, Virgen Macarena University Hospital, Seville, Spain.; Andalusian Network for Clinical and Translational Research in Neurology (NEURO-RECA), Malaga, Spain., Sánchez-Pérez RM; Neurology Service, University Hospital of Alicante, Alicante, Spain., Rubi-Callejon J; Neurology Unit, Internal Medicine Service, Hospital del Poniente de Almería, El Ejido (Almería), Spain.; Andalusian Network for Clinical and Translational Research in Neurology (NEURO-RECA), Malaga, Spain., Estévez-María JC; Neurology Service, Reina Sofia University Hospital, Cordoba, Spain.; Andalusian Network for Clinical and Translational Research in Neurology (NEURO-RECA), Malaga, Spain., Galeano-Bilbao B; Neurology Service, Puerta del Mar University Hospital, Cadiz, Spain.; Andalusian Network for Clinical and Translational Research in Neurology (NEURO-RECA), Malaga, Spain., Romero-Imbroda J; Neurology Service, Regional University Hospital of Malaga, Malaga, Spain.; Neurology Service, Hospital Quirón-Salud Málaga, Malaga, Spain.; Andalusian Network for Clinical and Translational Research in Neurology (NEURO-RECA), Malaga, Spain., Sobrino B; Infectious Diseases Service, Regional University Hospital of Malaga, Malaga, Spain., Arrabal-Gomez C; Andalusian Network for Clinical and Translational Research in Neurology (NEURO-RECA), Malaga, Spain., Oliver-Martos B; Neuroimmunology and Neuroinflamation Group, Institute of Biomedical Research of Malaga (IBIMA), Malaga, Spain.; Andalusian Network for Clinical and Translational Research in Neurology (NEURO-RECA), Malaga, Spain., Muñoz-Becerra L; Neurology Service, Regional University Hospital of Malaga, Malaga, Spain.; Neuroimmunology and Neuroinflamation Group, Institute of Biomedical Research of Malaga (IBIMA), Malaga, Spain.; Andalusian Network for Clinical and Translational Research in Neurology (NEURO-RECA), Malaga, Spain., Requena N; Neurology Service, Virgen de la Victoria University Hospital, Malaga, Spain.; Andalusian Network for Clinical and Translational Research in Neurology (NEURO-RECA), Malaga, Spain., González Álvarez de Sotomayor MDM; Neurology Service, Regional University Hospital of Malaga, Malaga, Spain.; Neuroimmunology and Neuroinflamation Group, Institute of Biomedical Research of Malaga (IBIMA), Malaga, Spain.; Andalusian Network for Clinical and Translational Research in Neurology (NEURO-RECA), Malaga, Spain., Estivill-Torrus G; Neurology Service, Regional University Hospital of Malaga, Malaga, Spain.; Neuroimmunology and Neuroinflamation Group, Institute of Biomedical Research of Malaga (IBIMA), Malaga, Spain.; Andalusian Network for Clinical and Translational Research in Neurology (NEURO-RECA), Malaga, Spain., Suarez J; Neuropsychopharmacology Group, Institute of Biomedical Research of Malaga (IBIMA), Malaga, Spain.; Andalusian Network for Clinical and Translational Research in Neurology (NEURO-RECA), Malaga, Spain., Ciano-Petersen NL; Neurology Service, Regional University Hospital of Malaga, Malaga, Spain.; Neuroimmunology and Neuroinflamation Group, Institute of Biomedical Research of Malaga (IBIMA), Malaga, Spain.; Andalusian Network for Clinical and Translational Research in Neurology (NEURO-RECA), Malaga, Spain., Pons-Pons G; Neurology Service, Regional University Hospital of Malaga, Malaga, Spain.; Andalusian Network for Clinical and Translational Research in Neurology (NEURO-RECA), Malaga, Spain., Reyes-Bueno JA; Neurology Service, Regional University Hospital of Malaga, Malaga, Spain.; Neuroimmunology and Neuroinflamation Group, Institute of Biomedical Research of Malaga (IBIMA), Malaga, Spain.; Andalusian Network for Clinical and Translational Research in Neurology (NEURO-RECA), Malaga, Spain., Cabezudo-Garcia P; Neurology Service, Regional University Hospital of Malaga, Malaga, Spain.; Neuroimmunology and Neuroinflamation Group, Institute of Biomedical Research of Malaga (IBIMA), Malaga, Spain.; Andalusian Network for Clinical and Translational Research in Neurology (NEURO-RECA), Malaga, Spain., Aguilar-Castillo MJ; Biotechnology Unit, Regional University Hospital of Malaga, Malaga, Spain.; Andalusian Network for Clinical and Translational Research in Neurology (NEURO-RECA), Malaga, Spain., De la Cruz Cosme C; Neurology Service, Virgen de la Victoria University Hospital, Malaga, Spain.; Andalusian Network for Clinical and Translational Research in Neurology (NEURO-RECA), Malaga, Spain., Duque-Holguera M; Neurology Service, University Hospital of Cáceres, Cáceres, Spain., Cuartero-Rodriguez E; Neurology Service, Valme University Hospital, Seville, Spain.; Andalusian Network for Clinical and Translational Research in Neurology (NEURO-RECA), Malaga, Spain., Vilches-Carrillo RM; Neurology Service, Virgen de las Nieves University Hospital, Granada, Spain.; Andalusian Network for Clinical and Translational Research in Neurology (NEURO-RECA), Malaga, Spain., Carrera-Muñoz I; Neurology Service, Virgen de las Nieves University Hospital, Granada, Spain.; Andalusian Network for Clinical and Translational Research in Neurology (NEURO-RECA), Malaga, Spain., Carnero-Pardo C; Fydian Neurocenter, Granada, Spain., Ramirez-Garcia T; Neurology Service, Torrecárdenas University Hospital, Almería, Spain.; Andalusian Network for Clinical and Translational Research in Neurology (NEURO-RECA), Malaga, Spain., Oropesa JM; Neurology Service, Juan Ramón Jiménez University Hospital, Huelva, Spain.; Andalusian Network for Clinical and Translational Research in Neurology (NEURO-RECA), Malaga, Spain., Dominguez-Mayoral A; Neurology Service, Virgen Macarena University Hospital, Seville, Spain.; Andalusian Network for Clinical and Translational Research in Neurology (NEURO-RECA), Malaga, Spain., Pelaez-Viñas N; Neurology Service, Reina Sofia University Hospital, Cordoba, Spain.; Andalusian Network for Clinical and Translational Research in Neurology (NEURO-RECA), Malaga, Spain., Valiente L; Infectious Diseases Service, Regional University Hospital of Malaga, Malaga, Spain., de Fonseca FR; Neuropsychopharmacology Group, Institute of Biomedical Research of Malaga (IBIMA), Malaga, Spain. fernando.rodriguez@ibima.eu.; Andalusian Network for Clinical and Translational Research in Neurology (NEURO-RECA), Malaga, Spain. fernando.rodriguez@ibima.eu.; Neuropsychopharmacology Group, Instituto IBIMA, Hospital Regional Universitario de Málaga (España), Avda Carlos-Haya S/N, Malaga, Spain. fernando.rodriguez@ibima.eu.
Publikováno v:
Scientific reports [Sci Rep] 2022 Mar 03; Vol. 12 (1), pp. 3563. Date of Electronic Publication: 2022 Mar 03.
Autor:
Chaturvedi, S, Zivin, J, Breazna, A, Amarenco, P, Callahan, A, Goldstein, LB, Hennerici, M, Sillesen, H, Rudolph, A, Welch, MA, SPARCL Investigators, Crimmins D, Davis S, Dimmitt S, Donnan G, Frayne J, Freilich D, Zagami A, Mikocki J, Schmidauer C, Schmidt R, De Bleecker J, Deceuninck F, Tack P, Thijs V, Gomes Fernandes J, Beaudry M, Cote R, Hoyte K, Lebrun LH, Mackey A, Sahlas D, Selchen D, Shuaib A, Spence JD, Teal P, Winger M, Matamala G, Cifkova R, Kalita Z, Rektor I, Rosolova H, Stipal R, Vaclavik D, Boysen G, Klingenberg H, Iversen, Sillesen H, Hillbom M, Kaste M, Numminen H, Pilke A, Salmivaara A, Sivenius J, Alamowitch S, Amarenco P, Boulliat J, De Broucker T, Chollet F, Mahagne MH, Milandre L, Moulin T, Bogdahn U, Diener HC, Dichgans M, Glahn J, Haberl R, Harms L, Hennerici MG, Knecht S, Kroczek G, Lichy C, Sander D, Schneider D, Kazis A, Karageorgiou C, Milonas I, Stathis P, Vogiatzoglou D, Bornstein N, Honigman S, Lampl Y, Streifler J, Capurso A, Comi G, Gandolfo C, Poloni M, Senin U, Rangel Guerra R, Boon AM, De Keyser JH, De Kort PL, Haas JA, Kamphuis DJ, Koudstaal PJ, Anderson N, Scott R, Singh G, Czlonkowska A, Drozdowski W, Gralewski Z, Kozubski W, Kuczynska Zardzewialy A, Podemski R, Stelmasiak Z, Szczudlik A, Da Costa Correia C, Ferro J, Salgueiro e. Cunha L, Lietava J, Raslova K, Carr J, Gardiner J, Kruger A, Alvarez Sabin J, Chamorro A, Diez Tejedor E, Fernández O, Trejo Gabriel y. Galán J, González Marcos J, Egido Herrero J, Jiménez Martínez M, Lago Martin A, Mostacero Miguel E, Vivancos Mora J, Moltó J, Viguera Romero J, Cuartero Rodriguez E, Rodriguez F, Serena J, Laska AC, Leijd B, Strand T, Terent A, Waegner A, Wallén T, Baumgartner R, Bogousslavsky J, Hungerbühler H, Lyrer P, Mattle H, Bath PM, Ekpo EB, Freeman A, Lees KR, MacLeod MJ, MacWalter RS, Sharma AK, Shetty HG, Albers G, Altafullah I, Benavente O, Book D, Broderick J, Callahan A. 3rd, Calder C, Carlini W, Chaturvedi S, Chippendale T, Clark W, Coull B, Davis P, Devlin T, Dick A, Dooneief G, Duff R, Estronza N, Forteza A, Frankel M, Frey J, Friday G, Graham G, Goldstein J, Hammer M, Harris J, Harper W, Hendin B, Hendin D, Hinton R, Hollander J, Hughes R, Kasner S, Kent T, Kim L, Kirshner H, LaMonte M, Ledbetter L, Lee Kwen P, Levin K, Libman R, Matlock J, McDowell P, McGee F. Jr, Meyer B, Minagar A, Moussouttas M, Munson R, Nash M, Nassief A, Orr S, Ratinov G, Salanga V, Silliman S, Singer R, Smith D, Sullivan H, Tietjen G, Thaler D, Tuchman M, Uskavitch D, Verro P, Vicari R, Weinstein R, Wilterdink J, Zweifler R, De Bastos M., FERRARESE, CARLO
Publikováno v:
Neurology. 72:688-694
BACKGROUND: It is unclear whether patients age 65 years and over with a recent stroke or TIA benefit from statin treatment to a similar degree as younger patients. METHODS: The 4,731 patient cohort in the SPARCL study was divided into an elderly grou
Autor:
Goldstein, LB, Amarenco, P, Lamonte, M, Gilbert, S, Messig, M, Callahan, A, Hennerici, M, Sillesen, H, Welch, KMA, SPARCL investigators, Bogousslavsky J, Goldstein LB, Zivin J, Clark W, Dávalos A, Kaste M, Leiter L, Altafullah I, Graham G, Glahn J, Jiménez Hernández D, MacWalter R, Scott R, Shuaib A, Sivenius J, Stipal R, Hart R, Marsh J, Norrving B, Pocock S, Sacco R, Easton J, Brown M, Nagy Z, Whisnant J, O'Neill B, Kleber F, LaBlanche JM, Welty F, Crimmins D, Davis S, Dimmitt S, Donnan G, Frayne J, Freilich D, Zagami A, Mikocki J, Schmidauer C, Schmidt R, De Bleecker J, Deceuninck F, Tack P, Thijs V, Gomes Fernandes J, Beaudry M, Cote R, Hoyte K, Lebrun LH, Mackey A, Sahlas D, Selchen D, Spence JD, Teal P, Winger M, Matamala G, Cifkova R, Kalita Z, Rektor I, Rosolova H, Vaclavik D, Boysen G, Klingenberg H, Sillesen H, Hillbom M, Numminen H, Pilke A, Salmivaara A, Alamowitch S, Amarenco P, Boulliat J, De Broucker T, Chollet F, Mahagne MH, Milandre L, Moulin T, Milonas I, Stathis P, Vogiatzoglou D, Bornstein N, Honigman S, Lampl Y, Streifler J, Capurso A, Comi G, Gandolfo C, Poloni M, Senin U, Rangel Guerra R, Boon AM, De Keyser JH, De Kort PL, Haas JA, Kamphuis DJ, Koudstaal PJ, Anderson N, Singh G, Czlonkowska A, Drozdowski W, Gralewski Z, Kozubski W, Kuczynska Zardzewialy A, Podemski R, Stelmasiak Z, Szczudlik A, Da Costa Correia C, Ferro J, Salgueiro e. Cunha L, Lietava J, Raslova K, Carr J, Gardiner J, Kruger A, Alvarez Sabin J, Chamorro A, Diez Tejedor E, Fernández O, Trejo Gabriel y. Galán J, González Marcos J, Egido Herrero J, Jiménez Martínez M, Lago Martin A, Mostacero Miguel E, Vivancos Mora J, Moltó J, Viguera Romero J, Cuartero Rodriguez E, Rubio F, Serena J, Laska AC, Leijd B, Strand T, Terent A, Waegner A, Wallén T, Baumgartner R, Hungerbühler H, Lyrer P, Mattle H, Bath PM, Ekpo EB, Freeman A, Lees KR, MacLeod MJ, MacWalter RS, Sharma AK, Shetty HG, Albers G, Benavente O, Book D, Broderick J, Calder C, Carlini W, Chaturvedi S, Chippendale T, Coull B, Davis P, Devlin T, Dick A, Dooneief G, Duff R, Estronza N, Forteza A, Frankel M, Frey J, Friday G, Goldstein J, Hammer M, Harris J, Harper W, Hendin B, Hess D, Hinton R, Hollander J, Hughes R, Kasner S, Kent T, Kim L, Kirshner H, LaMonte M, Ledbetter L, Lee Kwen P, Levin K, Libman R, Matlock J, McDowell P, McGee F. Jr, Meyer B, Minagar A, Moussouttas M, Munson R, Nash M, Nassief A, Orr S, Ratinov G, Salanga V, Silliman S, Singer R, Smith D, Sullivan H, Tietjen G, Thaler D, Tuchman M, Uskavitch D, Verro P, Vicari R, Weinstein R, Wilterdink J, Zweifler R, De Bastos M., FERRARESE, CARLO
Publikováno v:
Stroke. 39(9)
Background and Purpose— In SPARCL, treatment with atorvastatin 80 mg daily reduced stroke risk in patients with recent stroke or TIA and no known coronary heart disease by 16% versus placebo over 4.9 years of follow-up. The purpose of this secondar
Autor:
Saikarthik, Jayakumar, Saraswathi, Ilango, Alarifi, Abdulaziz, Al-Atram, Abdulrahman A., Mickeymaray, Suresh, Paramasivam, Anand, Shaikh, Saleem, Jeraud, Mathew, Alothaim, Abdulaziz S.
Publikováno v:
PeerJ; Nov2022, p1-34, 34p
Autor:
Widmann CN; Clinical Neuropsychology, Department of Neurodegenerative Diseases and Geriatric Psychiatry, University of Bonn Medical Center, Venusberg-Campus 1, 53127, Bonn, Germany. Catherine.widmann@ukbonn.de.; German Center for Neurodegenerative Diseases, Göttingen, Germany. Catherine.widmann@ukbonn.de., Henkel C; Clinical Neuropsychology, Department of Neurodegenerative Diseases and Geriatric Psychiatry, University of Bonn Medical Center, Venusberg-Campus 1, 53127, Bonn, Germany., Seibert S; Clinical Neuropsychology, Department of Neurodegenerative Diseases and Geriatric Psychiatry, University of Bonn Medical Center, Venusberg-Campus 1, 53127, Bonn, Germany.; German Center for Neurodegenerative Diseases, Göttingen, Germany.
Publikováno v:
Advances in experimental medicine and biology [Adv Exp Med Biol] 2024; Vol. 1458, pp. 59-76.
Neurocognitive and neuropsychiatric disorders contribute to a substantial amount of global morbidity and, as such, the identification of their causes is paramount to understanding their underlying pathophysiology as well as treatment and prevention s